Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia
Status:
Unknown status
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
This is open label single side study involvement 20 patient treated with Apremilast. Each
enrolled patient may be evaluated at by a dermatologist using the Lichen Planopilaris
Activity Index and Frontal Fibrosing Alopecia Index. Other measures include physician global
assessment, dermatology quality of life and patients analogue score for pruritus. Pt will
have visits at Week 0,2,4,8,12,16,20,24